tiprankstipranks
Trending News
More News >
Nuvectis Pharma, Inc. (NVCT)
:NVCT
US Market
Advertisement

Nuvectis Pharma (NVCT) Similar Stocks

Compare
108 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Nuvectis Pharma
$7.29
$144.17M
-9.80%
2 Buy
0 Hold
0 Sell
Moderate Buy
Immutep
$1.81
$253.25M
-4.23%
1 Buy
0 Hold
0 Sell
Moderate Buy
Monopar Therapeutics Inc
$40.10
$247.36M
1358.18%
5 Buy
1 Hold
0 Sell
Strong Buy
Compass Therapeutics
$2.93
$405.17M
175.25%
6 Buy
0 Hold
0 Sell
Strong Buy
Humacyte
$2.47
$342.81M
-69.12%
3 Buy
0 Hold
0 Sell
Strong Buy
Third Harmonic Bio, Inc.
$5.38
$242.79M
-50.46%
0 Buy
0 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NVCT
Nuvectis Pharma
6.17
-0.67
-9.80%
IMMP
Immutep
1.81
-0.08
-4.23%
MNPR
Monopar Therapeutics Inc
40.10
37.35
1358.18%
CMPX
Compass Therapeutics
2.78
1.77
175.25%
HUMA
Humacyte
2.47
-5.53
-69.12%
THRD
Third Harmonic Bio, Inc.
5.38
-5.48
-50.46%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis